Screener
Janux Therapeutics JANX Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Janux Therapeutics’s reported figures.
The source filing: Janux Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:18 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338078
FAQ
- What is Janux Therapeutics's enterprise value?
- Janux Therapeutics (JANX) reported enterprise value of $929.94M in Q2 2026.
- How has Janux Therapeutics's enterprise value changed year-over-year?
- Janux Therapeutics's enterprise value decreased by 31.2% year-over-year, from $1.35B to $929.94M.
- What is the long-term trend for Janux Therapeutics's enterprise value?
- Over 4 years (2021 to 2025), Janux Therapeutics's enterprise value has grown at a 0.6% compound annual growth rate (CAGR), from $779.77M to $799.84M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Janux Therapeutics's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude